nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—skin cancer	0.524	1	CbGaD
Diflunisal—ALB—Vismodegib—skin cancer	0.149	0.466	CbGbCtD
Diflunisal—ALB—Vemurafenib—skin cancer	0.118	0.368	CbGbCtD
Diflunisal—ALB—Fluorouracil—skin cancer	0.053	0.166	CbGbCtD
Diflunisal—Gastrointestinal perforation—Docetaxel—skin cancer	0.00264	0.0218	CcSEcCtD
Diflunisal—PTGS2—leg—skin cancer	0.00261	0.0864	CbGeAlD
Diflunisal—PTGS2—hindlimb—skin cancer	0.00233	0.0771	CbGeAlD
Diflunisal—TTR—neck—skin cancer	0.00229	0.0758	CbGeAlD
Diflunisal—UGT1A8—head—skin cancer	0.00211	0.0697	CbGeAlD
Diflunisal—PTGS2—appendage—skin cancer	0.002	0.0662	CbGeAlD
Diflunisal—Proteinuria—Imiquimod—skin cancer	0.00197	0.0163	CcSEcCtD
Diflunisal—Protein urine present—Imiquimod—skin cancer	0.00194	0.016	CcSEcCtD
Diflunisal—Photosensitivity—Vemurafenib—skin cancer	0.00168	0.0139	CcSEcCtD
Diflunisal—PTGS2—skin epidermis—skin cancer	0.00167	0.055	CbGeAlD
Diflunisal—TTR—connective tissue—skin cancer	0.00164	0.0543	CbGeAlD
Diflunisal—Muscle spasms—Vismodegib—skin cancer	0.00138	0.0114	CcSEcCtD
Diflunisal—Cholestasis—Temozolomide—skin cancer	0.00136	0.0113	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Imiquimod—skin cancer	0.00133	0.011	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00133	0.011	CcSEcCtD
Diflunisal—PTGS1—endothelium—skin cancer	0.00126	0.0418	CbGeAlD
Diflunisal—PTGS2—endothelium—skin cancer	0.00121	0.0399	CbGeAlD
Diflunisal—TTR—lymphoid tissue—skin cancer	0.0012	0.0397	CbGeAlD
Diflunisal—PTGS1—blood vessel—skin cancer	0.00117	0.0385	CbGeAlD
Diflunisal—Photosensitivity reaction—Vemurafenib—skin cancer	0.00116	0.0096	CcSEcCtD
Diflunisal—TTR—female reproductive system—skin cancer	0.00116	0.0383	CbGeAlD
Diflunisal—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00112	0.0093	CcSEcCtD
Diflunisal—PTGS2—blood vessel—skin cancer	0.00111	0.0368	CbGeAlD
Diflunisal—Hearing impaired—Temozolomide—skin cancer	0.00109	0.009	CcSEcCtD
Diflunisal—Dyspepsia—Vismodegib—skin cancer	0.00103	0.00852	CcSEcCtD
Diflunisal—Decreased appetite—Vismodegib—skin cancer	0.00102	0.00842	CcSEcCtD
Diflunisal—Dysuria—Imiquimod—skin cancer	0.00101	0.00839	CcSEcCtD
Diflunisal—Fatigue—Vismodegib—skin cancer	0.00101	0.00835	CcSEcCtD
Diflunisal—Constipation—Vismodegib—skin cancer	0.001	0.00828	CcSEcCtD
Diflunisal—Disorientation—Bleomycin—skin cancer	0.000997	0.00824	CcSEcCtD
Diflunisal—Photosensitivity reaction—Imiquimod—skin cancer	0.00099	0.00819	CcSEcCtD
Diflunisal—TTR—head—skin cancer	0.000968	0.032	CbGeAlD
Diflunisal—Erythema multiforme—Vemurafenib—skin cancer	0.000963	0.00796	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.000959	0.00793	CcSEcCtD
Diflunisal—Gastrointestinal pain—Vismodegib—skin cancer	0.000958	0.00792	CcSEcCtD
Diflunisal—Olsalazine—PTGS2—skin cancer	0.000953	0.222	CrCbGaD
Diflunisal—Aminosalicylic Acid—PTGS2—skin cancer	0.000896	0.208	CrCbGaD
Diflunisal—PTGS1—nipple—skin cancer	0.000843	0.0279	CbGeAlD
Diflunisal—Deafness—Temozolomide—skin cancer	0.000841	0.00695	CcSEcCtD
Diflunisal—Asthenia—Vismodegib—skin cancer	0.00084	0.00695	CcSEcCtD
Diflunisal—Visual impairment—Imiquimod—skin cancer	0.000837	0.00692	CcSEcCtD
Diflunisal—Pruritus—Vismodegib—skin cancer	0.000829	0.00685	CcSEcCtD
Diflunisal—Erythema multiforme—Imiquimod—skin cancer	0.000821	0.00679	CcSEcCtD
Diflunisal—Salsalate—PTGS2—skin cancer	0.00081	0.189	CrCbGaD
Diflunisal—Tinnitus—Imiquimod—skin cancer	0.00081	0.00669	CcSEcCtD
Diflunisal—Flushing—Imiquimod—skin cancer	0.000806	0.00666	CcSEcCtD
Diflunisal—Diarrhoea—Vismodegib—skin cancer	0.000801	0.00662	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Temozolomide—skin cancer	0.000797	0.00659	CcSEcCtD
Diflunisal—Photosensitivity—Fluorouracil—skin cancer	0.000789	0.00653	CcSEcCtD
Diflunisal—Disorientation—Fluorouracil—skin cancer	0.000775	0.00641	CcSEcCtD
Diflunisal—Bronchospasm—Bleomycin—skin cancer	0.000758	0.00627	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.000749	0.00619	CcSEcCtD
Diflunisal—Vomiting—Vismodegib—skin cancer	0.000745	0.00616	CcSEcCtD
Diflunisal—Rash—Vismodegib—skin cancer	0.000738	0.0061	CcSEcCtD
Diflunisal—Dermatitis—Vismodegib—skin cancer	0.000738	0.0061	CcSEcCtD
Diflunisal—Hearing impaired—Docetaxel—skin cancer	0.000724	0.00599	CcSEcCtD
Diflunisal—Anaphylactic shock—Vemurafenib—skin cancer	0.000724	0.00598	CcSEcCtD
Diflunisal—Mesalazine—PTGS2—skin cancer	0.000703	0.164	CrCbGaD
Diflunisal—Nausea—Vismodegib—skin cancer	0.000696	0.00575	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.000693	0.00573	CcSEcCtD
Diflunisal—Angioedema—Imiquimod—skin cancer	0.000691	0.00571	CcSEcCtD
Diflunisal—Syncope—Imiquimod—skin cancer	0.000678	0.00561	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000678	0.0056	CcSEcCtD
Diflunisal—Stomatitis—Bleomycin—skin cancer	0.00067	0.00554	CcSEcCtD
Diflunisal—Palpitations—Imiquimod—skin cancer	0.000668	0.00552	CcSEcCtD
Diflunisal—Loss of consciousness—Imiquimod—skin cancer	0.000665	0.00549	CcSEcCtD
Diflunisal—Haematuria—Bleomycin—skin cancer	0.000655	0.00542	CcSEcCtD
Diflunisal—Chest pain—Imiquimod—skin cancer	0.000644	0.00532	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000636	0.00525	CcSEcCtD
Diflunisal—Decreased appetite—Vemurafenib—skin cancer	0.000629	0.0052	CcSEcCtD
Diflunisal—Stomatitis—Dactinomycin—skin cancer	0.000625	0.00517	CcSEcCtD
Diflunisal—Fatigue—Vemurafenib—skin cancer	0.000624	0.00516	CcSEcCtD
Diflunisal—Constipation—Vemurafenib—skin cancer	0.000619	0.00512	CcSEcCtD
Diflunisal—Oedema—Imiquimod—skin cancer	0.000617	0.0051	CcSEcCtD
Diflunisal—Lightheadedness—Docetaxel—skin cancer	0.000617	0.0051	CcSEcCtD
Diflunisal—Dysuria—Temozolomide—skin cancer	0.000608	0.00503	CcSEcCtD
Diflunisal—Shock—Imiquimod—skin cancer	0.000607	0.00502	CcSEcCtD
Diflunisal—Agranulocytosis—Dactinomycin—skin cancer	0.000598	0.00495	CcSEcCtD
Diflunisal—PTGS1—connective tissue—skin cancer	0.000598	0.0198	CbGeAlD
Diflunisal—Hyperhidrosis—Imiquimod—skin cancer	0.000597	0.00493	CcSEcCtD
Diflunisal—Photosensitivity reaction—Temozolomide—skin cancer	0.000594	0.00491	CcSEcCtD
Diflunisal—Anorexia—Imiquimod—skin cancer	0.000588	0.00486	CcSEcCtD
Diflunisal—Hepatitis—Dactinomycin—skin cancer	0.000575	0.00476	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000575	0.00475	CcSEcCtD
Diflunisal—Flushing—Bleomycin—skin cancer	0.000573	0.00473	CcSEcCtD
Diflunisal—Body temperature increased—Vemurafenib—skin cancer	0.000572	0.00473	CcSEcCtD
Diflunisal—PTGS2—connective tissue—skin cancer	0.000571	0.0189	CbGeAlD
Diflunisal—PTGS1—epithelium—skin cancer	0.000568	0.0188	CbGeAlD
Diflunisal—Stomatitis—Temozolomide—skin cancer	0.000565	0.00467	CcSEcCtD
Diflunisal—Deafness—Docetaxel—skin cancer	0.000559	0.00462	CcSEcCtD
Diflunisal—Insomnia—Imiquimod—skin cancer	0.000558	0.00461	CcSEcCtD
Diflunisal—Paraesthesia—Imiquimod—skin cancer	0.000554	0.00458	CcSEcCtD
Diflunisal—Dyspnoea—Imiquimod—skin cancer	0.00055	0.00455	CcSEcCtD
Diflunisal—Somnolence—Imiquimod—skin cancer	0.000549	0.00454	CcSEcCtD
Diflunisal—Photosensitivity reaction—Fluorouracil—skin cancer	0.000547	0.00452	CcSEcCtD
Diflunisal—Erythema multiforme—Dactinomycin—skin cancer	0.000544	0.0045	CcSEcCtD
Diflunisal—Dyspepsia—Imiquimod—skin cancer	0.000543	0.00449	CcSEcCtD
Diflunisal—PTGS2—epithelium—skin cancer	0.000543	0.0179	CbGeAlD
Diflunisal—PTGS1—skin of body—skin cancer	0.00054	0.0178	CbGeAlD
Diflunisal—Decreased appetite—Imiquimod—skin cancer	0.000536	0.00443	CcSEcCtD
Diflunisal—Flushing—Dactinomycin—skin cancer	0.000534	0.00442	CcSEcCtD
Diflunisal—Hypersensitivity—Vemurafenib—skin cancer	0.000533	0.00441	CcSEcCtD
Diflunisal—Fatigue—Imiquimod—skin cancer	0.000532	0.0044	CcSEcCtD
Diflunisal—Visual disturbance—Docetaxel—skin cancer	0.000528	0.00436	CcSEcCtD
Diflunisal—Renal impairment—Docetaxel—skin cancer	0.000526	0.00435	CcSEcCtD
Diflunisal—Stomatitis—Fluorouracil—skin cancer	0.000521	0.0043	CcSEcCtD
Diflunisal—Hepatitis—Temozolomide—skin cancer	0.000521	0.0043	CcSEcCtD
Diflunisal—Asthenia—Vemurafenib—skin cancer	0.000519	0.00429	CcSEcCtD
Diflunisal—Hallucination—Temozolomide—skin cancer	0.000518	0.00428	CcSEcCtD
Diflunisal—PTGS2—skin of body—skin cancer	0.000516	0.0171	CbGeAlD
Diflunisal—Pruritus—Vemurafenib—skin cancer	0.000512	0.00423	CcSEcCtD
Diflunisal—Feeling abnormal—Imiquimod—skin cancer	0.000509	0.0042	CcSEcCtD
Diflunisal—Gastrointestinal pain—Imiquimod—skin cancer	0.000505	0.00417	CcSEcCtD
Diflunisal—Visual impairment—Temozolomide—skin cancer	0.000502	0.00415	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.0005	0.00414	CcSEcCtD
Diflunisal—Agranulocytosis—Fluorouracil—skin cancer	0.000499	0.00412	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—skin cancer	0.000498	0.116	CrCbGaD
Diflunisal—Diarrhoea—Vemurafenib—skin cancer	0.000495	0.00409	CcSEcCtD
Diflunisal—PTGS1—mammalian vulva—skin cancer	0.000492	0.0163	CbGeAlD
Diflunisal—Erythema multiforme—Temozolomide—skin cancer	0.000492	0.00407	CcSEcCtD
Diflunisal—Urticaria—Imiquimod—skin cancer	0.00049	0.00405	CcSEcCtD
Diflunisal—Body temperature increased—Imiquimod—skin cancer	0.000488	0.00403	CcSEcCtD
Diflunisal—Tinnitus—Temozolomide—skin cancer	0.000485	0.00401	CcSEcCtD
Diflunisal—Flushing—Temozolomide—skin cancer	0.000483	0.00399	CcSEcCtD
Diflunisal—Dizziness—Vemurafenib—skin cancer	0.000478	0.00396	CcSEcCtD
Diflunisal—Vomiting—Vemurafenib—skin cancer	0.00046	0.0038	CcSEcCtD
Diflunisal—Chest pain—Bleomycin—skin cancer	0.000457	0.00378	CcSEcCtD
Diflunisal—Rash—Vemurafenib—skin cancer	0.000456	0.00377	CcSEcCtD
Diflunisal—Dermatitis—Vemurafenib—skin cancer	0.000456	0.00377	CcSEcCtD
Diflunisal—Hypersensitivity—Imiquimod—skin cancer	0.000455	0.00376	CcSEcCtD
Diflunisal—Headache—Vemurafenib—skin cancer	0.000453	0.00375	CcSEcCtD
Diflunisal—Cramp muscle—Docetaxel—skin cancer	0.000451	0.00372	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000451	0.00372	CcSEcCtD
Diflunisal—Asthenia—Imiquimod—skin cancer	0.000443	0.00366	CcSEcCtD
Diflunisal—Confusional state—Bleomycin—skin cancer	0.000442	0.00365	CcSEcCtD
Diflunisal—Oedema—Bleomycin—skin cancer	0.000438	0.00362	CcSEcCtD
Diflunisal—Anaphylactic shock—Bleomycin—skin cancer	0.000438	0.00362	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—skin cancer	0.000437	0.102	CrCbGaD
Diflunisal—Pruritus—Imiquimod—skin cancer	0.000437	0.00361	CcSEcCtD
Diflunisal—ALB—lymph node—skin cancer	0.000433	0.0143	CbGeAlD
Diflunisal—Nausea—Vemurafenib—skin cancer	0.00043	0.00355	CcSEcCtD
Diflunisal—Thrombocytopenia—Bleomycin—skin cancer	0.000429	0.00355	CcSEcCtD
Diflunisal—Vision blurred—Temozolomide—skin cancer	0.000427	0.00353	CcSEcCtD
Diflunisal—Bronchospasm—Docetaxel—skin cancer	0.000425	0.00352	CcSEcCtD
Diflunisal—Diarrhoea—Imiquimod—skin cancer	0.000422	0.00349	CcSEcCtD
Diflunisal—PTGS1—female reproductive system—skin cancer	0.000422	0.0139	CbGeAlD
Diflunisal—Anorexia—Bleomycin—skin cancer	0.000418	0.00345	CcSEcCtD
Diflunisal—PTGS2—lymphoid tissue—skin cancer	0.000418	0.0138	CbGeAlD
Diflunisal—Angioedema—Temozolomide—skin cancer	0.000414	0.00342	CcSEcCtD
Diflunisal—Oedema—Dactinomycin—skin cancer	0.000409	0.00338	CcSEcCtD
Diflunisal—Dizziness—Imiquimod—skin cancer	0.000408	0.00337	CcSEcCtD
Diflunisal—Vertigo—Temozolomide—skin cancer	0.000407	0.00337	CcSEcCtD
Diflunisal—PTGS2—female reproductive system—skin cancer	0.000403	0.0133	CbGeAlD
Diflunisal—Palpitations—Temozolomide—skin cancer	0.0004	0.00331	CcSEcCtD
Diflunisal—Thrombocytopenia—Dactinomycin—skin cancer	0.0004	0.00331	CcSEcCtD
Diflunisal—Paraesthesia—Bleomycin—skin cancer	0.000394	0.00325	CcSEcCtD
Diflunisal—Vision blurred—Fluorouracil—skin cancer	0.000393	0.00325	CcSEcCtD
Diflunisal—Vomiting—Imiquimod—skin cancer	0.000392	0.00324	CcSEcCtD
Diflunisal—Dyspnoea—Bleomycin—skin cancer	0.000391	0.00323	CcSEcCtD
Diflunisal—Anorexia—Dactinomycin—skin cancer	0.00039	0.00322	CcSEcCtD
Diflunisal—Rash—Imiquimod—skin cancer	0.000389	0.00322	CcSEcCtD
Diflunisal—Dermatitis—Imiquimod—skin cancer	0.000389	0.00321	CcSEcCtD
Diflunisal—Headache—Imiquimod—skin cancer	0.000387	0.0032	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000382	0.00316	CcSEcCtD
Diflunisal—Decreased appetite—Bleomycin—skin cancer	0.000381	0.00315	CcSEcCtD
Diflunisal—Renal failure—Docetaxel—skin cancer	0.000379	0.00313	CcSEcCtD
Diflunisal—Stomatitis—Docetaxel—skin cancer	0.000376	0.00311	CcSEcCtD
Diflunisal—Jaundice—Docetaxel—skin cancer	0.000376	0.00311	CcSEcCtD
Diflunisal—Confusional state—Temozolomide—skin cancer	0.000373	0.00308	CcSEcCtD
Diflunisal—Oedema—Temozolomide—skin cancer	0.00037	0.00306	CcSEcCtD
Diflunisal—Anaphylactic shock—Temozolomide—skin cancer	0.00037	0.00306	CcSEcCtD
Diflunisal—Nausea—Imiquimod—skin cancer	0.000367	0.00303	CcSEcCtD
Diflunisal—Thrombocytopenia—Temozolomide—skin cancer	0.000362	0.00299	CcSEcCtD
Diflunisal—Feeling abnormal—Bleomycin—skin cancer	0.000361	0.00299	CcSEcCtD
Diflunisal—Agranulocytosis—Docetaxel—skin cancer	0.00036	0.00297	CcSEcCtD
Diflunisal—Hyperhidrosis—Temozolomide—skin cancer	0.000357	0.00296	CcSEcCtD
Diflunisal—Chest pain—Fluorouracil—skin cancer	0.000355	0.00294	CcSEcCtD
Diflunisal—Decreased appetite—Dactinomycin—skin cancer	0.000355	0.00294	CcSEcCtD
Diflunisal—Fatigue—Dactinomycin—skin cancer	0.000352	0.00291	CcSEcCtD
Diflunisal—Anorexia—Temozolomide—skin cancer	0.000352	0.00291	CcSEcCtD
Diflunisal—PTGS1—head—skin cancer	0.000352	0.0116	CbGeAlD
Diflunisal—Urticaria—Bleomycin—skin cancer	0.000348	0.00288	CcSEcCtD
Diflunisal—Body temperature increased—Bleomycin—skin cancer	0.000347	0.00286	CcSEcCtD
Diflunisal—Hepatitis—Docetaxel—skin cancer	0.000346	0.00286	CcSEcCtD
Diflunisal—Confusional state—Fluorouracil—skin cancer	0.000344	0.00284	CcSEcCtD
Diflunisal—Oedema—Fluorouracil—skin cancer	0.000341	0.00282	CcSEcCtD
Diflunisal—Anaphylactic shock—Fluorouracil—skin cancer	0.000341	0.00282	CcSEcCtD
Diflunisal—Feeling abnormal—Dactinomycin—skin cancer	0.000337	0.00279	CcSEcCtD
Diflunisal—PTGS2—head—skin cancer	0.000337	0.0111	CbGeAlD
Diflunisal—Insomnia—Temozolomide—skin cancer	0.000334	0.00277	CcSEcCtD
Diflunisal—Gastrointestinal pain—Dactinomycin—skin cancer	0.000334	0.00276	CcSEcCtD
Diflunisal—Thrombocytopenia—Fluorouracil—skin cancer	0.000334	0.00276	CcSEcCtD
Diflunisal—Visual impairment—Docetaxel—skin cancer	0.000334	0.00276	CcSEcCtD
Diflunisal—Paraesthesia—Temozolomide—skin cancer	0.000332	0.00275	CcSEcCtD
Diflunisal—Dyspnoea—Temozolomide—skin cancer	0.00033	0.00273	CcSEcCtD
Diflunisal—Somnolence—Temozolomide—skin cancer	0.000329	0.00272	CcSEcCtD
Diflunisal—Erythema multiforme—Docetaxel—skin cancer	0.000327	0.00271	CcSEcCtD
Diflunisal—Dyspepsia—Temozolomide—skin cancer	0.000326	0.00269	CcSEcCtD
Diflunisal—Anorexia—Fluorouracil—skin cancer	0.000325	0.00268	CcSEcCtD
Diflunisal—Body temperature increased—Dactinomycin—skin cancer	0.000323	0.00267	CcSEcCtD
Diflunisal—Hypersensitivity—Bleomycin—skin cancer	0.000323	0.00267	CcSEcCtD
Diflunisal—Decreased appetite—Temozolomide—skin cancer	0.000321	0.00266	CcSEcCtD
Diflunisal—Flushing—Docetaxel—skin cancer	0.000321	0.00266	CcSEcCtD
Diflunisal—Fatigue—Temozolomide—skin cancer	0.000319	0.00264	CcSEcCtD
Diflunisal—Constipation—Temozolomide—skin cancer	0.000316	0.00261	CcSEcCtD
Diflunisal—Asthenia—Bleomycin—skin cancer	0.000315	0.0026	CcSEcCtD
Diflunisal—Pruritus—Bleomycin—skin cancer	0.00031	0.00256	CcSEcCtD
Diflunisal—Insomnia—Fluorouracil—skin cancer	0.000308	0.00255	CcSEcCtD
Diflunisal—Paraesthesia—Fluorouracil—skin cancer	0.000306	0.00253	CcSEcCtD
Diflunisal—Feeling abnormal—Temozolomide—skin cancer	0.000305	0.00252	CcSEcCtD
Diflunisal—Dyspnoea—Fluorouracil—skin cancer	0.000304	0.00251	CcSEcCtD
Diflunisal—Somnolence—Fluorouracil—skin cancer	0.000303	0.0025	CcSEcCtD
Diflunisal—Gastrointestinal pain—Temozolomide—skin cancer	0.000302	0.0025	CcSEcCtD
Diflunisal—Hypersensitivity—Dactinomycin—skin cancer	0.000301	0.00249	CcSEcCtD
Diflunisal—Dyspepsia—Fluorouracil—skin cancer	0.0003	0.00248	CcSEcCtD
Diflunisal—Decreased appetite—Fluorouracil—skin cancer	0.000296	0.00245	CcSEcCtD
Diflunisal—Urticaria—Temozolomide—skin cancer	0.000294	0.00243	CcSEcCtD
Diflunisal—Asthenia—Dactinomycin—skin cancer	0.000293	0.00243	CcSEcCtD
Diflunisal—Body temperature increased—Temozolomide—skin cancer	0.000292	0.00242	CcSEcCtD
Diflunisal—Muscle spasms—Docetaxel—skin cancer	0.00029	0.00239	CcSEcCtD
Diflunisal—Feeling abnormal—Fluorouracil—skin cancer	0.000281	0.00232	CcSEcCtD
Diflunisal—Diarrhoea—Dactinomycin—skin cancer	0.00028	0.00231	CcSEcCtD
Diflunisal—Vomiting—Bleomycin—skin cancer	0.000279	0.0023	CcSEcCtD
Diflunisal—Rash—Bleomycin—skin cancer	0.000276	0.00229	CcSEcCtD
Diflunisal—Dermatitis—Bleomycin—skin cancer	0.000276	0.00228	CcSEcCtD
Diflunisal—Hypersensitivity—Temozolomide—skin cancer	0.000272	0.00225	CcSEcCtD
Diflunisal—Urticaria—Fluorouracil—skin cancer	0.000271	0.00224	CcSEcCtD
Diflunisal—Syncope—Docetaxel—skin cancer	0.00027	0.00223	CcSEcCtD
Diflunisal—Body temperature increased—Fluorouracil—skin cancer	0.000269	0.00223	CcSEcCtD
Diflunisal—Palpitations—Docetaxel—skin cancer	0.000266	0.0022	CcSEcCtD
Diflunisal—Asthenia—Temozolomide—skin cancer	0.000265	0.00219	CcSEcCtD
Diflunisal—Loss of consciousness—Docetaxel—skin cancer	0.000265	0.00219	CcSEcCtD
Diflunisal—Pruritus—Temozolomide—skin cancer	0.000262	0.00216	CcSEcCtD
Diflunisal—Nausea—Bleomycin—skin cancer	0.00026	0.00215	CcSEcCtD
Diflunisal—Vomiting—Dactinomycin—skin cancer	0.00026	0.00215	CcSEcCtD
Diflunisal—Rash—Dactinomycin—skin cancer	0.000258	0.00213	CcSEcCtD
Diflunisal—Chest pain—Docetaxel—skin cancer	0.000257	0.00212	CcSEcCtD
Diflunisal—Diarrhoea—Temozolomide—skin cancer	0.000253	0.00209	CcSEcCtD
Diflunisal—Hypersensitivity—Fluorouracil—skin cancer	0.000251	0.00208	CcSEcCtD
Diflunisal—Confusional state—Docetaxel—skin cancer	0.000248	0.00205	CcSEcCtD
Diflunisal—PTGS1—lymph node—skin cancer	0.000247	0.00815	CbGeAlD
Diflunisal—Anaphylactic shock—Docetaxel—skin cancer	0.000246	0.00203	CcSEcCtD
Diflunisal—Oedema—Docetaxel—skin cancer	0.000246	0.00203	CcSEcCtD
Diflunisal—Dizziness—Temozolomide—skin cancer	0.000245	0.00202	CcSEcCtD
Diflunisal—Nausea—Dactinomycin—skin cancer	0.000243	0.00201	CcSEcCtD
Diflunisal—Shock—Docetaxel—skin cancer	0.000242	0.002	CcSEcCtD
Diflunisal—Pruritus—Fluorouracil—skin cancer	0.000241	0.00199	CcSEcCtD
Diflunisal—Thrombocytopenia—Docetaxel—skin cancer	0.000241	0.00199	CcSEcCtD
Diflunisal—PTGS2—lymph node—skin cancer	0.000236	0.00779	CbGeAlD
Diflunisal—Vomiting—Temozolomide—skin cancer	0.000235	0.00194	CcSEcCtD
Diflunisal—Anorexia—Docetaxel—skin cancer	0.000234	0.00194	CcSEcCtD
Diflunisal—Rash—Temozolomide—skin cancer	0.000233	0.00193	CcSEcCtD
Diflunisal—Diarrhoea—Fluorouracil—skin cancer	0.000233	0.00193	CcSEcCtD
Diflunisal—Dermatitis—Temozolomide—skin cancer	0.000233	0.00193	CcSEcCtD
Diflunisal—Headache—Temozolomide—skin cancer	0.000232	0.00192	CcSEcCtD
Diflunisal—Dizziness—Fluorouracil—skin cancer	0.000225	0.00186	CcSEcCtD
Diflunisal—Insomnia—Docetaxel—skin cancer	0.000222	0.00184	CcSEcCtD
Diflunisal—Paraesthesia—Docetaxel—skin cancer	0.000221	0.00183	CcSEcCtD
Diflunisal—Nausea—Temozolomide—skin cancer	0.00022	0.00182	CcSEcCtD
Diflunisal—Dyspnoea—Docetaxel—skin cancer	0.000219	0.00181	CcSEcCtD
Diflunisal—Somnolence—Docetaxel—skin cancer	0.000219	0.00181	CcSEcCtD
Diflunisal—Vomiting—Fluorouracil—skin cancer	0.000217	0.00179	CcSEcCtD
Diflunisal—Dyspepsia—Docetaxel—skin cancer	0.000216	0.00179	CcSEcCtD
Diflunisal—Rash—Fluorouracil—skin cancer	0.000215	0.00178	CcSEcCtD
Diflunisal—Dermatitis—Fluorouracil—skin cancer	0.000215	0.00177	CcSEcCtD
Diflunisal—Decreased appetite—Docetaxel—skin cancer	0.000214	0.00177	CcSEcCtD
Diflunisal—Headache—Fluorouracil—skin cancer	0.000213	0.00176	CcSEcCtD
Diflunisal—Fatigue—Docetaxel—skin cancer	0.000212	0.00175	CcSEcCtD
Diflunisal—Constipation—Docetaxel—skin cancer	0.00021	0.00174	CcSEcCtD
Diflunisal—Feeling abnormal—Docetaxel—skin cancer	0.000203	0.00168	CcSEcCtD
Diflunisal—Nausea—Fluorouracil—skin cancer	0.000202	0.00167	CcSEcCtD
Diflunisal—Gastrointestinal pain—Docetaxel—skin cancer	0.000201	0.00166	CcSEcCtD
Diflunisal—Body temperature increased—Docetaxel—skin cancer	0.000194	0.00161	CcSEcCtD
Diflunisal—Hypersensitivity—Docetaxel—skin cancer	0.000181	0.0015	CcSEcCtD
Diflunisal—Asthenia—Docetaxel—skin cancer	0.000176	0.00146	CcSEcCtD
Diflunisal—Pruritus—Docetaxel—skin cancer	0.000174	0.00144	CcSEcCtD
Diflunisal—Diarrhoea—Docetaxel—skin cancer	0.000168	0.00139	CcSEcCtD
Diflunisal—Dizziness—Docetaxel—skin cancer	0.000163	0.00134	CcSEcCtD
Diflunisal—Vomiting—Docetaxel—skin cancer	0.000156	0.00129	CcSEcCtD
Diflunisal—Rash—Docetaxel—skin cancer	0.000155	0.00128	CcSEcCtD
Diflunisal—Dermatitis—Docetaxel—skin cancer	0.000155	0.00128	CcSEcCtD
Diflunisal—Headache—Docetaxel—skin cancer	0.000154	0.00127	CcSEcCtD
Diflunisal—Nausea—Docetaxel—skin cancer	0.000146	0.00121	CcSEcCtD
